Home › Overweight › Texas › Fort Worth
Overweight clinical trials in Fort Worth, TX
4 studies for Overweight are looking for participants at sites in and around Fort Worth (within about 30 miles). Open a study to see who can join and how to contact the study team.
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
RecruitingPhase 3
- Valley Institute of Research - Fort Worth, Fort Worth
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- North Hills Medical Research, North Richland Hills · 9 mi away
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
- Diabetes and Thyroid Center of Ft. Worth, Fort Worth
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RecruitingPhase 3
- North Hills Medical Research, North Richland Hills · 9 mi away
Overweight trials in other cities
- Houston, TX33 studies
- San Antonio, TX33 studies
- Chicago, IL28 studies
- Orlando, FL25 studies
- Las Vegas, NV23 studies
- Miami, FL23 studies
- Dallas, TX20 studies
- Atlanta, GA20 studies
- Jacksonville, FL19 studies
- Washington, DC19 studies
- New York City, NY19 studies
- Austin, TX18 studies
Other studies in Fort Worth
- Non-Small Cell Lung Cancer18 studies
- Ovarian Cancer17 studies
- Endometrial Cancer13 studies
- Breast Cancer11 studies
- Cancer (all types)10 studies
- Prostate Cancer9 studies
- Kidney Cancer (Renal Cell Carcinoma)7 studies
- Macular Degeneration7 studies
- Metastatic Cancer7 studies
- Heart Failure7 studies
- Colorectal Cancer7 studies
- Triple-Negative Breast Cancer7 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.